Panthenol for Health & Longevity
Evidence Review created on 11/15/2026 using AI4L + evidence-mcp / Opus 5.5
Also known as: Dexpanthenol, D-Panthenol, DL-Panthenol, Pantothenol, Pantothenyl Alcohol, Provitamin B5, Bepanthen, Ilopan
Motivation
Panthenol (provitamin B5) is a stable alcohol form of pantothenic acid, which the body converts into the vitamin itself. It is one of the most common ingredients in skin creams and wound ointments, and it also appears in oral vitamin products. Its appeal rests on a single idea: the vitamin it becomes is a building block of a molecule that cells use to make fats and release energy.
Panthenol ointments have been part of skin and wound care since the 1940s. More recently, laboratory and animal studies on how cells handle vitamin B5 during aging have drawn the attention of people focused on healthy aging.
This review examines the human evidence for and against panthenol in health- and longevity-oriented adults: which skin and whole-body effects have been tested, which harms such as skin allergy have been reported, how panthenol is used in practice, and which animal and laboratory findings have not yet been tested in people.
Benefits - Risks - Protocol - Conclusion
Recommended Reading
This section lists narrative reviews and research articles on panthenol and on pantothenic acid, the vitamin it becomes.
-
Topical use of dexpanthenol: a 70th anniversary article - Proksch et al., 2017
Narrative review of seven decades of topical dexpanthenol for skin barrier repair and wound healing, including newer molecular findings; three of four authors are employees of Bayer, which sells Bepanthen.
-
Panthenol Allergic Contact Dermatitis: Sources of Exposure, Reported Cases, and a Call for More Frequent Testing - Weber & Hylwa, 2025
Reviews published cases of allergic contact dermatitis (delayed skin allergy where a substance touches the skin) and contact urticaria (itchy raised welts) caused by panthenol, and lists common “gentle” products that contain it.
-
Primary research reporting severe brain depletion of pantothenic acid, the vitamin panthenol becomes, in Alzheimer’s disease; it underpins the longevity-oriented hypothesis that oral vitamin B5 deserves testing.
Only three items are listed because no further content discusses panthenol or pantothenic acid in substantial depth. Rhonda Patrick (FoundMyFitness) names panthenol only in a members-only, paywalled skincare answer; Chris Kresser and Life Extension Magazine give pantothenic acid only brief sections within broader articles; Peter Attia, Andrew Huberman and Lifespan.io returned no matching content.
Grokipedia
AI-generated encyclopedia entry covering panthenol’s chemistry and stereochemistry, conversion to pantothenic acid, medical and cosmetic uses, pharmacology and adverse effects, with 65 listed sources.
Examine
No Examine article on panthenol exists; a direct site search for “panthenol” returned no results.
ConsumerLab
No ConsumerLab article on panthenol exists; the site search returned only two unrelated reports in which the term may appear in member-only text.
Systematic Reviews
This section lists systematic reviews that evaluate dexpanthenol or pantothenic acid; no meta-analysis of panthenol itself was found.
-
Topical interventions to prevent acute radiation dermatitis in head and neck cancer patients: a systematic review - Ferreira et al., 2017
Thirteen trials including dexpanthenol; no strong evidence that any topical agent prevents radiation dermatitis (skin inflammation from radiotherapy).
-
Preventive and curative approaches to diaper dermatitis in children: a systematic review - Octarica et al., 2025
Thirteen pediatric studies; judges zinc oxide or dexpanthenol emollients effective for diaper dermatitis, with minimal side effects.
-
Prevention of and therapies for nipple pain: a systematic review - Morland-Schultz & Hill, 2005
Compares breastfeeding nipple treatments including dexpanthenol; no topical agent proved superior to education on latch-on technique.
-
Pantothenic Acid and Parkinson Disease: A Systematic Review of Metabolomics Analysis Studies - Kheirouri & Alizadeh, 2026
About pantothenic acid, not panthenol: most of 16 metabolomics (small-molecule profiling) studies found altered, mainly reduced, pantothenic acid in Parkinson’s disease.
The principal risk, allergic contact dermatitis, is unrepresented: no systematic review or meta-analysis of panthenol allergy was found.
Mechanism of Action
Panthenol is the alcohol form of pantothenic acid (vitamin B5). Tissues, including skin, convert it by oxidation to pantothenic acid, which cells use to build coenzyme A (CoA, a carrier molecule that moves acetyl and fatty-acid groups through energy and fat metabolism) Proksch 2002.
- Skin barrier: CoA drives early steps in making fatty acids and sphingolipids (fats that seal the outer skin layer), the proposed basis for barrier repair Proksch 2002. A newer explanation, summarized in a review of spectroscopy work (light-based measurement of skin molecules), credits greater mobility of existing outer-layer components Proksch 2017; the same review links the wound-healing effect, separately, to altered expression of genes important for wound healing Proksch 2017.
- Gut motility: CoA supplies the acetyl group for acetylcholine (the nerve messenger that drives gut contractions), the historical rationale for injections after surgery; a drug reference notes that this effect has not been proven AHFS pantothenic acid monograph.
- Selectivity: Panthenol acts as a nutrient precursor, not a receptor-targeted drug.
- Half-life: No human half-life has been reported. After 2 g intravenously, 10–30% appeared in urine as pantothenic acid within 24 hours Sachs 1990.
- Distribution and elimination: A scoping review reports that pantothenic acid enters cells through SMVT (sodium-dependent multivitamin transporter, shared with biotin and lipoic acid) Freese 2023, crosses into the brain Freese 2023, is stored mainly as CoA in mitochondria (cellular energy units) Freese 2023 and is excreted largely unchanged in urine Freese 2023. No cytochrome P450 (liver drug-metabolizing enzyme) pathway has been described.
Historical Context & Evolution
- Original use: Bepanthen ointment, the first topical dexpanthenol product, appeared about 70 years before 2017, according to a review Proksch 2017 and was originally sold by Roche Løkkevik 1996. Injected dexpanthenol (Ilopan) was used in the US against paralytic ileus (temporary stall of gut movement after surgery), per a drug reference AHFS pantothenic acid monograph.
- Path to health optimization: Healthy-aging interest rests on findings of reduced brain pantothenic acid in Alzheimer’s disease Xu 2020 and age-related CoA decline in fly intestinal stem cells Liu 2025, where CoA supplementation extended fly lifespan Liu 2025.
- What changed: Topical use shifted from wound ointment to everyday barrier care, per a review Proksch 2017, while a 1996 controlled trial found no clinically important benefit for radiotherapy skin reactions Løkkevik 1996. The US injection has since been discontinued AHFS pantothenic acid monograph. Recognition of panthenol as a contact allergen grew, with positive patch-test (skin test applying a suspected allergen under a patch for two days) rates rising from 0.2–0.7% to 1.2% in a review of published series Weber 2025.
- Current standing: Both the early ileus enthusiasm and the longevity hypothesis remain open: the first lacks modern trials, the second lacks any human outcome data.
Expected Benefits
High 🟩 🟩 🟩
Skin Barrier Repair and Hydration
Topical dexpanthenol sped repair of the skin’s water barrier and raised hydration of the stratum corneum (outermost skin layer) versus the identical cream without it (vehicle) in randomized controlled trials (RCTs) by Proksch Proksch 2002, who also found less redness Proksch 2002, and Gehring Gehring 2000. Biro found that pretreatment prevented the hydration loss caused by detergent irritation Biro 2003. Trials were small and short; two used irritated skin Proksch 2002 Biro 2003, one did not Gehring 2000. Bayer, which sells Bepanthen, employed authors of later emollient trials Stettler 2017.
Magnitude: The dexpanthenol forearm was rated better than the placebo forearm in 11 of 21 volunteers and worse in 1 Biro 2003, and skin hydration fell significantly only at placebo sites after irritation Biro 2003; the abstracts of the other two trials report statistical significance (a difference unlikely to be due to chance) without effect sizes (how large the difference was) Proksch 2002 Gehring 2000.
Throat Pain and Mucosal Healing After Airway Procedures ⭕️ Not Central to Health & Longevity
Dexpanthenol lozenges reduced throat pain in placebo-controlled RCTs from two independent groups. Celebi in Istanbul randomized 120 children after tonsillectomy and found less pain Celebi 2013 and better tonsil-wound healing Celebi 2013. Gulhas in Malatya randomized 180 patients aged 15–70 to dexpanthenol 200 mg, benzydamine spray or water spray before intubation (placing a breathing tube); the dexpanthenol group had fewer post-operative sore throats Gulhas 2007. The effect bears on recovery from airway procedures, not on aging or long-term health.
Magnitude: Sore-throat incidence was significantly lower than with placebo when lozenges were taken before intubation Gulhas 2007, and pain and healing scores were significantly better than placebo after tonsillectomy Celebi 2013; the accessible literature reports no outcome figure, as both trials report only statistical significance in their abstracts and no other retrievable source quantifies the effect.
Medium 🟩 🟩
Faster Healing of Superficial Skin Wounds ⭕️ Not Central to Health & Longevity
In a 38-patient randomized split-wound trial after fractional carbon-dioxide laser resurfacing of sun-damaged skin, areas treated with dexpanthenol ointment closed faster Heise 2019 and looked better on days 1–5 than areas treated with petroleum jelly Heise 2019. This is a single trial from one group, assessed partly by visual scoring. A randomized trial of a panthenol-enriched multi-ingredient mask after facial laser treatment Gao 2025 is not counted, because the other ingredients could explain the result. The finding bears on recovery from cosmetic procedures and minor abrasions.
Magnitude: Lesion diameters were significantly smaller on days 1 and 2 Heise 2019, and re-epithelialization (regrowth of surface skin) was better on days 1, 2 and 5 than with petroleum jelly Heise 2019, with all sites healed by day 14 Heise 2019; the report gives no effect-size figure.
Faster Healing of the Eye Surface ⚠️ Conflicted ⭕️ Not Central to Health & Longevity
In Gdańsk, 40 post-surgical eyes given 5% D-Panthenol drops and gel healed better than 40 untreated eyes Raczyńska 2003. In Ankara, 21 patients given corneal cross-linking (a light-activated treatment that stiffens a thinning cornea) re-epithelialized faster with dexpanthenol–hyaluronate than hyaluronate drops Sabur 2023; neither study was randomized. In Frankfurt, an 18-patient randomized trial found 5% dexpanthenol ointment no faster than its vehicle Baumeister 2009; vitamin A plus dexpanthenol was slower than calf-blood extract gel Egger 1999. It bears on eye-procedure recovery. Net reading: modest effect, unconfirmed by randomized trials.
Magnitude: Complete re-epithelialization took 2.24 days with dexpanthenol–hyaluronate drops versus 3.43 days with hyaluronate alone in fellow eyes (the same patient’s other eye), with no confidence interval (CI, the range likely to contain the true effect) reported Sabur 2023; in the randomized trial, epithelial closure took 57.5 hours with dexpanthenol versus 64.8 hours with vehicle, not a significant difference Baumeister 2009.
Low 🟩
Nasal Dryness Relief ⚠️ Conflicted ⭕️ Not Central to Health & Longevity
Dexpanthenol spray beat placebo on crusting and airflow in 48 rhinitis sicca (dry nose) patients Kehrl 1998. Added to hyaluronic acid spray, it improved perceived moistening but not symptom scores in 240 patients (maker Ursapharm co-authored) Thieme 2020. It bears on comfort, not aging. Net reading: no proven symptom advantage.
Magnitude: The dry-nose symptom score improved 8.42 points with hyaluronic acid plus dexpanthenol and 8.90 points with hyaluronic acid alone, with no significant difference between the two sprays Thieme 2020.
Radiation Dermatitis Prevention ⚠️ Conflicted ⭕️ Not Central to Health & Longevity
In 86 patients, dexpanthenol cream gave no clinically important benefit over no cream Løkkevik 1996. Another trial reported delayed peak dermatitis versus non-randomized untreated controls Schmuth 2002, though methylprednisolone (an anti-inflammatory steroid) did better Schmuth 2002. This bears on radiotherapy, not aging. Net reading: at most a delay, no prevention.
Magnitude: Share of patients whose cream-treated field fared better minus the share faring worse than the untreated field: erythema (skin reddening) 0.0 (95% CI −0.09 to 0.09) Løkkevik 1996, desquamation (skin peeling) 0.13 (95% CI 0.01 to 0.25) Løkkevik 1996, itching 0.06 (95% CI −0.07 to 0.19) Løkkevik 1996 and pain −0.03 (95% CI −0.11 to 0.05) Løkkevik 1996; the authors judged none clinically relevant Løkkevik 1996.
Diaper Dermatitis Treatment ⚠️ Conflicted ⭕️ Not Central to Health & Longevity
A systematic review judged emollients with zinc oxide or dexpanthenol effective, grouping both agents Octarica 2025. An RCT of dexpanthenol plus zinc oxide versus ointment base in 46 children with diarrhea found no severity difference Wananukul 2006. This bears on infant skin care. Net reading: added benefit unproven.
Magnitude: Complete clearance by day 7 was 58.7% on the dexpanthenol–zinc oxide side versus 56% on the ointment-base side Wananukul 2006.
Sore Nipple Care During Breastfeeding ⚠️ Conflicted ⭕️ Not Central to Health & Longevity
In 126 breastfeeding mothers with traumatic nipples, dexpanthenol cream relieved pain and trauma as well as lanolin or peppermint cream, with no placebo group Shanazi 2015. A systematic review found no topical agent superior to breastfeeding-technique education Morland-Schultz 2005. It bears on breastfeeding comfort. Net reading: no specific benefit shown.
Magnitude: Mean nipple-pain score fell from 3.07 to 0.14 by day 7 with dexpanthenol, versus 3.12 to 0.24 with lanolin and 3.07 to 0.21 with peppermint cream, with no significant difference between groups and no placebo group Shanazi 2015.
Faster Bowel Recovery After Surgery ⚠️ Conflicted ⭕️ Not Central to Health & Longevity
A 60-patient pilot with a saline control reported faster first bowel movement at higher injected doses Giraldi 2012. A drug reference, the AHFS monograph, states that well-controlled trials failed to show any benefit AHFS pantothenic acid monograph. This bears on surgical recovery only. Net reading: benefit unproven.
Magnitude: Higher dose predicted a shorter time to first bowel movement (regression coefficient, a measure of how strongly dose and time moved together, −0.868, P < 0.001; P is the probability that a result this strong arises by chance); the pilot gives no between-group difference figure Giraldi 2012.
Fewer Acne Lesions (Oral Pantothenic Acid) ⭕️ Not Central to Health & Longevity
In 41 adults, a supplement supplying 2.2 g/day of pantothenic acid reduced facial acne lesions versus placebo over 12 weeks Yang 2014. Evidence is indirect (pantothenic acid, not panthenol), from one trial sponsored by the marketer, Avilan Yang 2014. It bears on acne, not aging.
Magnitude: Total lesion count was 68.21% lower than with placebo at week 12, as reported by the authors without a confidence interval Yang 2014.
Lower Low-Density Lipoprotein Cholesterol (Pantethine Only)
Pantethine, a different vitamin B5 derivative, lowered low-density lipoprotein (LDL) cholesterol (the fraction linked to clogged arteries) versus placebo in 32 adults Evans 2014. Panthenol itself is untested, so the evidence is indirect; authors included employees of pantethine makers Daiichi Fine Chemical and Kyowa Hakko Evans 2014.
Magnitude: LDL cholesterol fell 11% from baseline with pantethine and rose 3% with placebo by week 16 (between-group P = 0.010) Evans 2014.
Protection Against Brain Aging
Pantothenic acid is depleted in Alzheimer’s disease brains Xu 2020 and in dementia with Lewy bodies (dementia with abnormal protein deposits) Scholefield 2024. The evidence is indirect: post-mortem levels of the body’s own vitamin were measured, not supplementation. Supplementation is untested.
Magnitude: Pantothenic acid was significantly lower in 6 of 10 brain regions in 20 people with dementia with Lewy bodies than in 19 controls Scholefield 2024; no study reports an outcome figure for supplementation.
Stronger Anti-Tumor Immunity
Pantothenate improved immune checkpoint antibody therapy (drugs releasing immune-cell brakes) in mice St Paul 2021, and higher pre-treatment plasma levels tracked better response in melanoma patients St Paul 2021. The human evidence is indirect: the body’s own levels were correlated with response, not supplementation tested.
Magnitude: Among 42 melanoma patients, those in the top third of plasma pantothenic acid were mostly responders and had a significantly longer time to next treatment St Paul 2021; the report gives this direction without an effect-size figure.
Speculative 🟨
Lifespan Extension
Pantothenic acid extended lifespan in Caenorhabditis elegans worms Jonk 2025; CoA extended fruit-fly lifespan Liu 2025. No human data exist; the basis is animal only.
Benefit-Modifying Factors
- Genetic polymorphisms: No gene variant is known to change panthenol’s benefit. Inherited defects of PANK2 (gene for pantothenate kinase, the first enzyme of CoA synthesis) cause a separate brain iron-accumulation disease, per a scoping review Freese 2023.
- Baseline biomarkers: Vehicle-controlled gains were shown after detergent irritation Proksch 2002; no trial has compared response on impaired versus intact skin. Oral vitamin B5 is unlikely to add much with adequate intake, because deficiency is rare according to a scoping review Freese 2023.
- Sex: In the pantethine lipid trial, LDL cholesterol fell 13% by week 8 in women Evans 2014, while men, fewer in number, showed no lipid change Evans 2014. No topical trial has reported a sex difference.
- Pre-existing conditions: Signals exist for irritated skin Proksch 2002, dry nose Kehrl 1998 and procedure wounds Heise 2019; in radiotherapy skin reactions, one trial found no clinically important benefit Løkkevik 1996 and another only a delay of peak dermatitis Schmuth 2002.
- Age: The placebo-controlled barrier trial enrolled adults aged 18–45 Biro 2003; adults over 65 have not been studied separately.
Potential Risks & Side Effects
High 🟥 🟥 🟥
No risk reaches High: harms come from case reports, patch-test series and a product label, not from replicated controlled trials.
Medium 🟥 🟥
No risk reaches Medium: no controlled trial or comparison-group study has measured a panthenol-specific harm.
Low 🟥
Allergic Reactions
Panthenol causes allergic contact dermatitis, including from wound-healing creams Blanchard 2022; 1.2% of 2,171 patch-tested patients reacted Fernandes 2018, mostly with chronic eczema Fernandes 2018. Contact urticaria, per a review Weber 2025, and injection allergies AHFS pantothenic acid monograph occur. A review describes anaphylaxis after oral dexpanthenol multivitamins Lis 2026.
Magnitude: 26 of 2,171 patients (1.2%) patch-tested from 2009 to 2017 reacted to dexpanthenol 5%; no control group Fernandes 2018.
Gastrointestinal Effects and Other Injection Reactions
A scoping review links pantothenic acid intakes of 10–20 g/day to occasional diarrhea and water retention Freese 2023, with no health risk up to 2 g/day Freese 2023; this concerns pantothenic acid, not panthenol. Injection reports include cramps, diarrhea, low blood pressure and agitation AHFS pantothenic acid monograph.
Magnitude: Daily intakes of 10–20 g have been related to water retention and occasional diarrhea; the scoping review reports no rate and no comparison group Freese 2023. The injection events are isolated reports with no established causal relationship, no denominator and no comparison group AHFS pantothenic acid monograph.
Allergic Inflammation of Heart and Lung Linings
A 76-year-old woman taking vitamins B5 and biotin for two months developed eosinophilic pleuropericarditis (fluid and allergy-type white cells around heart and lungs), resolving after withdrawal Debourdeau 2001. This is one case, with vitamin B5 of unstated form plus biotin.
Magnitude: Not quantified in available studies. Only a single case report exists, with no denominator or comparison group.
Speculative 🟨
Prolonged Bleeding in Hemophilia
The manufacturers state that injected dexpanthenol may prolong bleeding time and should be used with extreme caution, if at all, in hemophilia AHFS pantothenic acid monograph. The basis is a label precaution, not human reports.
Risk-Modifying Factors
- Genetic polymorphisms: No gene variant is known to raise the risk of panthenol allergy or side effects.
- Baseline biomarkers: No blood test predicts allergy; a prior positive patch test to dexpanthenol or to pantolactone (its chemical building block) marks people who react to wound-healing creams Blanchard 2022.
- Sex: No sex difference in reactions has been reported; heavy use of hair, skin and “hypoallergenic” products raises cumulative exposure, a review notes Weber 2025.
- Pre-existing conditions: Chronic eczema and multiple contact allergies concentrate risk: 88.5% of reactive patients were tested for chronic eczema Fernandes 2018 and 96.2% reacted to other allergens Fernandes 2018.
- Age: No study reports age-specific rates of panthenol allergy or side effects, and adults over 65 have not been studied separately.
Key Interactions & Contraindications
Documented interactions:
- Succinylcholine (short-acting anesthesia muscle relaxant; injection only): Avoid within one hour, per the manufacturers AHFS pantothenic acid monograph; prolonged effect and temporary breathing difficulty were reported AHFS pantothenic acid monograph, though the monograph notes a controlled trial found no prolongation AHFS pantothenic acid monograph.
- Antibiotics, opioids (strong painkillers) and barbiturates (sedatives) (cefazolin, morphine, phenobarbital); injection only: The manufacturers report rare allergic reactions of unknown cause with concomitant use AHFS pantothenic acid monograph; dexpanthenol is stopped at any sign of hypersensitivity AHFS pantothenic acid monograph.
- Anticholinergic drugs (drugs that block acetylcholine) and opioid antidiarrheals (oxybutynin, over-the-counter diphenhydramine, over-the-counter loperamide); injection only: Slowed gut motility counters injected dexpanthenol’s purpose; the manufacturer advises avoiding motility-decreasing drugs during ileus treatment AHFS pantothenic acid monograph.
- Parasympathomimetics and cholinesterase inhibitors (drugs mimicking or raising acetylcholine) (neostigmine, pyridostigmine, bethanechol); injection only: Additive gut stimulation is expected from shared acetylcholine activity; the manufacturers advise, on theoretical grounds, against dexpanthenol with or within 12 hours after these drugs AHFS pantothenic acid monograph.
- Hyaluronic acid nasal spray: Combined in a 240-patient randomized trial; tolerability matched either spray alone, so no interaction was found Thieme 2020.
- Sulfadimidine (sulfonamide antibiotic used to measure acetylation, a liver step that tags drugs for removal; pantothenic acid, not panthenol): 1,100 mg pantothenic acid daily (oral plus intravenous) for seven days left sulfadimidine kinetics unchanged in 21 mostly elderly subjects; no interaction found Vas 1990.
Theoretical interactions (inferred from mechanism, not studied in humans):
- Oral cholinesterase inhibitors (drugs that raise acetylcholine) (donepezil, rivastigmine) with gram-dose oral B5: Additive gut stimulation inferred from the proposed acetylcholine mechanism, risking cramping or diarrhea; watching for abdominal symptoms mitigates it.
- High-dose biotin and alpha-lipoic acid supplements: Competition for the shared SMVT transporter is inferred to reduce uptake of each; separating doses by several hours mitigates it.
- Other vitamin B5 sources (calcium pantothenate, pantethine, B-complex products): Additive pantothenic acid load inferred from the shared end product; counting the total daily dose keeps intake below the gram range linked to diarrhea.
- Occlusive (airtight) dressings and ablative skin procedures (treatments that remove the surface skin layer): Broken or occluded skin is inferred to increase penetration and sensitization risk; a small-area trial on intact skin first mitigates it.
Populations who should avoid Panthenol:
- Known allergy to panthenol, dexpanthenol or pantolactone: Dexpanthenol and pantolactone allergy is documented by patch testing Blanchard 2022; panthenol allergy is documented in reported cases, per a review Weber 2025.
- Pregnancy, unless clearly needed (injectable form): No animal reproduction studies exist and fetal harm is unknown AHFS pantothenic acid monograph; the injection is used in pregnancy only when clearly needed AHFS pantothenic acid monograph.
- Hemophilia (injectable form): Inferred from a possible prolongation of bleeding time, which the manufacturers cite as a precaution AHFS pantothenic acid monograph; no human reports.
- Succinylcholine within the preceding hour (injectable form): Manufacturers’ warning AHFS pantothenic acid monograph.
- Mechanical bowel obstruction (injectable form): The injection should not be used for mechanical obstruction, which needs correction of the blockage itself AHFS pantothenic acid monograph.
Risk Mitigation Strategies
Doses and timings below follow common practice unless cited.
- Small-area use test: Applying the product to a coin-sized forearm area twice daily for 3–5 days before wider use screens for allergic contact dermatitis.
- Patch testing when dermatitis persists: Dermatology patch testing with dexpanthenol 5% in petroleum jelly identifies dexpanthenol allergy Fernandes 2018, including allergy hidden in “hypoallergenic” products, a review notes Weber 2025, preventing ongoing eczema.
- Stop at first sign of hypersensitivity: The manufacturers specify discontinuation at any sign of hypersensitivity AHFS pantothenic acid monograph, limiting spreading rashes, urticaria and delayed wound healing.
- Oral dose ceiling: Keeping total pantothenic acid at or below 2 g/day, which a scoping review links to no health risk Freese 2023, avoids the diarrhea and water retention seen at 10–20 g/day Freese 2023.
- Eosinophil check with high-dose B5 plus biotin: New chest pain or breathlessness on this pairing prompts an eosinophil count, the marker raised in the pleuropericarditis case Debourdeau 2001.
- Succinylcholine spacing: Allowing at least one hour between succinylcholine and dexpanthenol injection AHFS pantothenic acid monograph prevents prolonged muscle relaxation and breathing difficulty.
- Ingredient-list checks: Reading labels of “hypoallergenic” skin and hair products for panthenol prevents unrecognized re-exposure after a diagnosed allergy, as a review notes Weber 2025.
Therapeutic Protocol
Parameters without a citation (timing, frequency, cycling, titration steps) reflect common practice.
- Topical barrier care: 5% dexpanthenol cream or ointment twice daily Biro 2003; a drug reference lists 2% cream once or twice daily AHFS pantothenic acid monograph; this approach was popularized by Roche’s Bepanthen Løkkevik 1996, now sold by Bayer.
- Procedure and wound aftercare: Dexpanthenol ointment applied under occlusion for 7 days after laser resurfacing Heise 2019.
- Throat and mouth: Two dexpanthenol pastilles (200 mg) sucked 30 minutes before intubation Gulhas 2007.
- Nose: Dexpanthenol nasal spray four times daily for six weeks after sinus surgery Tantilipikorn 2012.
- Oral nutrition (competing approaches): Adequate intake is 5 mg/day, per a scoping review Freese 2023; Leung popularized gram-dose pantothenic acid for acne Leung 1995, tested at 2.2 g/day Yang 2014; a lipid trial used pantethine 600–900 mg/day Evans 2014.
- Injection (clinical only): 250–500 mg intramuscularly, repeated at 2 hours and then every 4–12 hours as needed, to stimulate gut movement after surgery, per a drug reference AHFS pantothenic acid monograph; no longevity use.
- Time of day: No time-of-day data exist; topical use after washing or bathing, and oral doses with meals, are customary.
- Half-life: No human half-life has been reported; 10–30% of an intravenous dose is excreted within 24 hours Sachs 1990, supporting repeated daily application.
- Single or split dosing: Topical products are applied twice daily; gram oral doses are split, as in the acne trial’s twice-daily regimen Yang 2014.
- Genetic polymorphisms: No pharmacogenetic dose guidance exists; PANK2 disease is managed separately from wellness use.
- Sex: No sex-specific dosing exists; response may differ, as the pantethine lipid trial found a 13% LDL cholesterol fall in women Evans 2014 and no lipid change in men Evans 2014.
- Age: The nasal trial enrolled adults aged 23–63 Tantilipikorn 2012; older adults use the same topical strength, with closer watch for dermatitis on fragile skin.
- Baseline biomarkers: Urinary pantothenic acid below 1 mg/day indicates low status, per a scoping review Freese 2023, the only setting where oral repletion has a clear rationale.
- Pre-existing conditions: Chronic eczema and multiple contact allergies concentrate allergic reactions Fernandes 2018, the setting in which a small-area test or patch test is most informative.
Discontinuation & Cycling
- Duration: Topical use is episodic, for irritated skin, wounds or dry nose, and stops on healing; dietary pantothenic acid intake is lifelong by nature.
- Withdrawal effects: None reported for topical, oral or injected panthenol.
- Tapering: Not needed; panthenol can be stopped at once.
- Cycling: No tolerance or loss of effect has been described, so cycling has no evidence-based rationale.
Sourcing and Quality
- D- versus DL-Panthenol: Only the D-form (dexpanthenol) converts to active vitamin B5; DL-Panthenol is half inactive L-form, so pharmaceutical products specify dexpanthenol.
- Strength and base: The placebo-controlled forearm trial used 5% dexpanthenol Biro 2003; ointments occlude more than creams, and fragrance-free bases reduce exposure to other skin allergens.
- Oral forms: Most single-ingredient B5 supplements contain calcium pantothenate rather than panthenol; third-party marks such as US Pharmacopeia (USP) Verified or NSF Certified confirm label content and purity.
- Reputable products: Bepanthen (Bayer) is the reference dexpanthenol ointment; La Roche-Posay Cicaplast Baume B5 is a widely used panthenol balm; Life Extension sells calcium pantothenate capsules.
- “Hypoallergenic” labels: Such claims do not exclude panthenol, a review notes Weber 2025, so ingredient lists matter for anyone allergic.
Practical Considerations
- Time to effect: Barrier and hydration gains appeared within 7 days Gehring 2000; wound effects within 1–5 days Heise 2019. No timeline exists for longevity effects.
- Common pitfalls: Confusing panthenol with pantethine; expecting oral B5 to slow aging; assuming “hypoallergenic” means panthenol-free; using DL-Panthenol believing it equals dexpanthenol.
- Regulatory status: Topical panthenol is common in personal-care products and pharmaceuticals, a review notes Weber 2025; the US injection has been discontinued, per a drug reference AHFS pantothenic acid monograph. A scoping review finds no tolerable upper intake level Freese 2023.
- Cost and access: Inexpensive and widely available in pharmacies and personal-care products.
Interaction with Foundational Habits
- Sleep: None. No study links panthenol to sleep quality or timing; bedtime application of ointment is a practical habit only.
- Nutrition: Indirect. Liver, kidney, egg yolk, broccoli, mushrooms and avocado supply pantothenic acid Kresser skin-nutrition article, and high-heat processing and canning can remove up to 75% of it Kresser skin-nutrition article; a varied whole-food diet usually meets the 5 mg/day adequate intake cited in a scoping review Freese 2023.
- Exercise: None studied. Topical dexpanthenol is used on friction-chafed or sweat-irritated skin, a direct barrier use; no effect on performance or muscle adaptation is documented.
- Stress management: None documented. Older claims of B5 as an “anti-stress” vitamin lack human trials; no effect on cortisol has been shown.
Monitoring Protocol & Defining Success
Baseline: No laboratory test is required before topical use. For people with chronic eczema or several known contact allergies, patch testing with dexpanthenol 5% in petroleum jelly identifies allergy before regular use Fernandes 2018. Before oral gram-dose pantothenic acid, especially combined with biotin, a complete blood count with eosinophils provides a reference point Debourdeau 2001. Urinary or whole-blood pantothenic acid is optional and mainly useful when dietary intake is in doubt.
Ongoing: For topical use, skin is reviewed at 1 week, 4 weeks, then every 3–6 months for new rashes at application sites. For oral gram doses, the eosinophil count is repeated at 8–12 weeks and then every 6–12 months, sooner if chest pain or breathlessness appears. Pantothenic acid levels are rechecked only after a dose change.
| Biomarker | Optimal Functional Range | Why Measure It? | Context/Notes |
|---|---|---|---|
| 24-hour urinary pantothenic acid | 1 mg/day or more (below 1 mg/day indicates low status; scoping review, Freese 2023) | Marker the intervention changes: rises with oral intake | Most reliable status indicator; a scoping review considers below 1 mg/day low Freese 2023 and gives no adequacy cut-off Freese 2023; complete 24-hour collection; reflects recent intake |
| Whole-blood pantothenic acid | 1.6–2.7 µmol/L (standard reference range) | Marker the intervention changes: rises with oral intake | A scoping review considers below 1 µmol/L low Freese 2023; only moderately correlated with intake; not widely offered; no fasting needed |
| Eosinophil count (complete blood count) | 0–500 cells/µL (standard reference range) | Safety check: a rise stops gram-dose oral use | Relevant to gram-dose B5, especially with biotin; the reported case reached 1,200–1,500 cells/mm³ Debourdeau 2001; pair with C-reactive protein if symptoms appear; any time of day |
Qualitative markers:
- Skin dryness, roughness and tightness at treated sites
- Redness, itch or new eczema at application sites (allergy signal)
- Days to closure of minor wounds or procedure sites
- Nasal crusting and ease of nasal breathing
- Bowel comfort, stool consistency and fluid retention with oral gram doses
Emerging Research
- Vitamin B5 with cancer immunotherapy (NCT06377111): Phase 1, 12 adults with advanced melanoma on nivolumab plus ipilimumab (checkpoint antibodies) take 2,000 mg/day calcium pantothenate; primary endpoint is a 50% plasma rise; active, completion 2027. A positive result supports testing the immunity signal; a null result weakens it.
- Injected dexpanthenol for chronic wounds (NCT07395674): Pilot randomized trial in 40 adults with diabetic, venous or arterial ulcers; perilesional (around-the-wound) injections plus standard care versus standard care; primary endpoint wound-area change; completion 2028. A positive result extends the wound benefit to chronic wounds; a null result confines it to superficial wounds.
- Dexpanthenol eye drops after cataract surgery (NCT07581548): Observational comparison of 300 patients using hyaluronate with 2% dexpanthenol versus two other tear substitutes; endpoints are dryness questionnaire scores and tear stability; completion 2027. A positive result supports epithelial benefits; a null result suggests no advantage over other drops.
- Panthenol balm for cancer-therapy skin toxicity (NCT07767448): Stanford study, with L’Oréal (maker of La Roche-Posay) as collaborator, of 50 participants using moisturizers including Cicaplast Baume B5; primary endpoint patient-reported dryness; completion 2029. A positive result strengthens barrier claims in damaged skin; a null result echoes the radiotherapy findings.
- Dexpanthenol eye drops after laser eye surgery (NCT06822608): Phase 4 randomized, placebo-controlled trial of dexpanthenol–hyaluronic acid drops, one eye each, in 68 patients after PRK (laser reshaping of the cornea); primary endpoint re-epithelialization time; registered as not yet recruiting, estimated completion January 2026. A positive result upgrades the eye-surface benefit; a null result weakens it.
- Dexpanthenol hydrogel patch for abrasions (NCT07642973): Randomized within-person trial in 40 healthy adults comparing a dexpanthenol hydrogel patch with a standard plaster on standardized abrasions; primary endpoint re-epithelialization rate; completion 2026. A positive result supports the superficial-wound benefit; a null result questions it.
- Pantothenic acid and neurodegeneration: A systematic review finds reduced pantothenic acid across most Parkinson’s metabolomics studies Kheirouri 2026, and a post-mortem study found it reduced in Lewy body dementia brains Scholefield 2024; supplementation trials could confirm or refute a protective role.
- CoA decline in aging tissues: Lifespan gains in flies Liu 2025 and worms Jonk 2025 need replication in mammals; failure in mice would leave the longevity case without support.
- Allergy surveillance: Rising patch-test positivity reported in a review Weber 2025 could reveal a larger burden if panthenol joins baseline allergen series, weakening the case for routine use.
Conclusion
Panthenol is a stable form of vitamin B5 found in countless skin, hair and nasal products. For health- and longevity-focused adults, its clearest strength is local: on skin, it helps the outer layer hold water and recover after irritation, and lozenges ease throat soreness after airway procedures. Wound healing after skin procedures has a promising but single-study signal. Claims for nasal dryness, skin protection during radiotherapy and diaper rash are mixed, and oral benefits for acne or cholesterol come from related compounds rather than panthenol itself.
The longevity interest rests on the vitamin’s role in a central metabolic molecule whose levels fall with age in some animals and in diseased human brains. Worm and fly studies show longer life, but no human study has tested whether extra panthenol slows aging, protects the brain or helps the immune system fight cancer.
Risks are low but real. Skin allergy is the main concern, is probably under-recognized, and appears mostly in people with long-standing eczema and other allergies. Very large oral amounts of the vitamin can cause diarrhea and fluid retention, and an injectable form carries rare allergic reactions and a timing issue with an anesthesia muscle relaxant.
The evidence base is small, often short-term, and partly produced or sponsored by companies that sell these products, including the maker of the best-known ointment. Panthenol is best understood as a well-tolerated skin and lining-tissue care ingredient with a modest local evidence base, while its role in aging remains an untested idea.